Voyager Therapeutics, Inc.
MX ˙ BMV ˙ US92915B1061
SecurityMX:VYGR / Voyager Therapeutics, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership948,226 shares
Latest Disclosed Value $ 3,660,152
State Street Corp reports 1.28% increase in ownership of VYGR / Voyager Therapeutics, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 948,226 shares of Voyager Therapeutics, Inc. (MX:VYGR) valued at $3,660,152 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 936,266 shares of Voyager Therapeutics, Inc.. This represents a change in shares of 1.28% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 948,226 11,960 1.28 3,660 -0.52 0.0001
2026-02-13 2025-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 936,266 10,908 1.18 3,680 -14.86 0.0001
2025-11-14 2025-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 925,358 31,438 3.52 4,321 55.43 0.0001
2025-08-14 2025-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 893,920 -8,832 -0.98 2,780 -8.88 0.0001
2025-05-15 2025-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 902,752 1,820 0.20 3,051 -40.27 0.0001
2025-02-14 2024-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 900,932 8,189 0.92 5,108 -2.18 0.0002
2024-11-14 2024-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 892,743 -896,446 -50.10 5,223 -63.10 0.0002
2024-08-14 2024-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 1,789,189 40,021 2.29 14,152 -13.09 0.0006
2024-05-15 2024-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,749,168 1,129,356 182.21 16,285 211.30 0.0007
2024-02-14 2023-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 619,812 37,583 6.46 5,231 15.94 0.0003
2023-11-14 2023-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 582,229 37,365 6.86 4,512 -27.67 0.0003
2023-08-14 2023-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 544,864 450,767 479.05 6,239 760.41 0.0003
2023-05-15 2023-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 94,097 5,300 5.97 725 34.01 0.0000
2023-05-15 2022-12-31 13F/A-99 VOYAGER THERAPEUTICS COM 92915B106 88,797 0 0.00 542 2.85 0.0000
2023-05-15 2022-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 88,797 0 542 0.0000
2022-11-15 2022-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 88,797 0 0.00 526 0.19 0.0000
2022-08-15 2022-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 88,797 -4,600 -4.93 525 -26.26 0.0000
2022-05-16 2022-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 93,397 8,583 10.12 712 209.57 0.0000
2022-02-14 2021-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 84,814 0 0.00 230 3.14 0.0000
2021-11-15 2021-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 84,814 0 0.00 223 -36.29 0.0000
2021-08-16 2021-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 84,814 -405,656 -82.71 350 -84.85 0.0000
2021-07-09 2021-03-31 13F/A-1 VOYAGER THERAPEUTICS COM 92915B106 490,470 -64,410 -11.61 2,310 -41.77 0.0001
2021-05-17 2021-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 490,470 -64,410 2,310 0.0001
2021-02-16 2020-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 554,880 -11,679 -2.06 3,967 -34.38 0.0002
2020-11-10 2020-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 566,559 -715,307 -55.80 6,045 -62.63 0.0004
2020-08-14 2020-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 1,281,866 -87,784 -6.41 16,177 29.09 0.0012
2020-06-19 2020-03-31 13F/A-1 VOYAGER THERAPEUTICS COM 92915B106 1,369,650 44,002 3.32 12,532 -32.23 0.0011
2020-05-11 2020-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,369,650 44,002 12,532 1,100.5619
2020-02-06 2019-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,325,648 -85,139 -6.03 18,493 -23.83 0.0013
2019-11-14 2019-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 1,410,787 202,283 16.74 24,280 -26.19 0.0018
2019-08-14 2019-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 1,208,504 830,409 219.63 32,895 354.54 0.0025
2019-05-15 2019-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 378,095 12,540 3.43 7,237 110.62 0.0006
2019-02-12 2018-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 365,555 -936,733 -71.93 3,436 -86.06 0.0003
2018-11-09 2018-09-30 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 1,302,288 72,376 5.88 24,640 2.51 0.0019
2018-08-14 2018-06-30 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 1,229,912 430,966 53.94 24,037 60.12 0.0020
2018-05-15 2018-03-31 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 798,946 566,786 244.14 15,012 289.52 0.0013
2018-02-14 2017-12-31 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 232,160 33,502 16.86 3,854 -5.75 0.0003
2017-11-14 2017-09-30 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 198,658 14,132 7.66 4,089 147.37 0.0004
2017-08-14 2017-06-30 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 184,526 19,471 11.80 1,653 -24.35 0.0001
2017-05-15 2017-03-31 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 165,055 -448 -0.27 2,185 3.65 0.0002
2017-02-09 2016-12-31 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 165,503 8,257 5.25 2,108 11.59 0.0002
2017-01-13 2016-09-30 13F/A-1 VOYAGER THERAPEUTICS Common equity shares 92915B106 157,246 14,635 10.26 1,889 20.70 0.0002
2016-11-14 2016-09-30 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 157,246 1,889
2016-08-12 2016-06-30 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 142,611 84,906 147.14 1,565 211.75 0.0002
2016-05-20 2016-03-31 13F/A-1 VOYAGER THERAPEUTICS Common equity shares 92915B106 57,705 11,900 25.98 502 -49.95 0.0001
2016-05-12 2016-03-31 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 57,705 502
2016-02-16 2015-12-31 13F VOYAGER THERAPEUTICS Common equity shares 92915B106 45,805 45,805 1,003 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.